Cresset BioMolecular Discovery Launches FieldStere  
2/5/2009 2:51:15 PM

WELWYN GARDEN CITY, England – 21 January 2009: Cresset BioMolecular Discovery Ltd (Cresset) announces today the launch of FieldStere, a new software product that enables medicinal chemists to enrich their shortlist of drug candidates with structurally diverse compounds that share the same desired biological activity (bioisosteres). FieldStere allows the fine-tuning of the resulting bioisosteres to enhance potency and specificity whilst removing undesirable ADME and physical properties.